Doximity (DOCS) – Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Doximity (NYSE: DOCS) recently:

• 8/13/2026 – Doximity had its price target raised by Truist Financial Corporation from $19.00 to $24.00. They now have a “hold” rating on the stock.
• 8/13/2026 – Doximity was upgraded by Wolfe Research to “outperform”.
• 8/12/2026 – Doximity had its “sell (d+)” rating reaffirmed by Weiss Ratings.
• 8/10/2026 – Doximity was downgraded by Wells Fargo & Company from “equal weight” to “underweight”. They now have a $18.00 price target on the stock.
• 8/7/2026 – Doximity had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $41.00 price target on the stock.
• 8/7/2026 – Doximity was given a new $40.00 price target by Evercore Inc.
• 8/7/2026 – Doximity had its “market perform” rating reaffirmed by BMO Capital Markets. They now have a $30.00 price target on the stock.
• 8/7/2026 – Doximity was given a new $36.00 price target by Canaccord Genuity Group Inc..
• 8/7/2026 – Doximity had its “overweight” rating reaffirmed by Piper Sandler. They now have a $47.00 price target on the stock, up from $42.00.
• 8/7/2026 – Doximity had its price target raised by JPMorgan Chase & Co. from $26.00 to $31.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – Doximity was upgraded by Zacks Research from “strong sell” to “hold”.
• 6/29/2026 – Doximity was downgraded by Citigroup Inc. to “underperform”.
• 6/29/2026 – Doximity had its “underperform” rating reaffirmed by Bank of America Corporation. They now have a $20.00 price target on the stock, down from $38.00.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 7,500 shares of Doximity stock in a transaction on Friday, August 7th. The stock was sold at an average price of $39.11, for a total transaction of $293,325.00. Following the transaction, the director owned 3,221 shares in the company, valued at approximately $125,973.31. The trade was a 69.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 1,770 shares of the company’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $24.94, for a total value of $44,143.80. Following the transaction, the chief accounting officer directly owned 97,004 shares in the company, valued at $2,419,279.76. The trade was a 1.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 11,714 shares of company stock valued at $387,351. 31.80% of the stock is currently owned by insiders.

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.